SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-068760
Filing Date
2020-03-10
Accepted
2020-03-10 16:10:34
Documents
3
Period of Report
2020-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d753184d8k.htm 8-K 17531
2 EX-99.1 d753184dex991.htm EX-99.1 58859
3 GRAPHIC g753184dsp07.jpg GRAPHIC 15975
  Complete submission text file 0001193125-20-068760.txt   99718
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39041 | Film No.: 20701623
SIC: 2834 Pharmaceutical Preparations